Lee Bowman

1.5k total citations
45 papers, 1.1k citations indexed

About

Lee Bowman is a scholar working on Economics and Econometrics, Oncology and Epidemiology. According to data from OpenAlex, Lee Bowman has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 11 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Lee Bowman's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Economic and Financial Impacts of Cancer (11 papers) and Healthcare Policy and Management (5 papers). Lee Bowman is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Economic and Financial Impacts of Cancer (11 papers) and Healthcare Policy and Management (5 papers). Lee Bowman collaborates with scholars based in United States, United Kingdom and Japan. Lee Bowman's co-authors include Lucie Kutikova, Stacey R. Long, William H. Crown, Stella Chang, Charles L. Bennett, Denise Finley, Curtis D. Black, James M. Russell, Ronald Landbloom and Eduardo Dunayevich and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Lee Bowman

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee Bowman United States 21 303 265 172 167 159 45 1.1k
Anne-Françoise Gaudin France 20 413 1.4× 135 0.5× 270 1.6× 191 1.1× 183 1.2× 67 1.5k
Jacqueline Brown United Kingdom 20 279 0.9× 162 0.6× 129 0.8× 271 1.6× 273 1.7× 50 1.4k
Michael Eaddy United States 21 203 0.7× 257 1.0× 180 1.0× 59 0.4× 234 1.5× 96 1.5k
Anuja Roy United States 11 210 0.7× 344 1.3× 142 0.8× 219 1.3× 150 0.9× 41 2.2k
K. Jack Ishak United States 21 507 1.7× 438 1.7× 387 2.3× 144 0.9× 209 1.3× 43 2.0k
Anita Burrell United States 9 181 0.6× 383 1.4× 139 0.8× 203 1.2× 129 0.8× 22 2.0k
Karen Welch United Kingdom 22 274 0.9× 171 0.6× 316 1.8× 228 1.4× 479 3.0× 40 1.8k
Dong D. Zhang United States 11 301 1.0× 97 0.4× 121 0.7× 284 1.7× 203 1.3× 15 982
Irina Proskorovsky United States 17 255 0.8× 178 0.7× 262 1.5× 169 1.0× 195 1.2× 65 1.2k
Jennifer Christian United States 20 128 0.4× 177 0.7× 305 1.8× 225 1.3× 117 0.7× 61 1.2k

Countries citing papers authored by Lee Bowman

Since Specialization
Citations

This map shows the geographic impact of Lee Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Bowman more than expected).

Fields of papers citing papers by Lee Bowman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Bowman. The network helps show where Lee Bowman may publish in the future.

Co-authorship network of co-authors of Lee Bowman

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Bowman. A scholar is included among the top collaborators of Lee Bowman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Bowman. Lee Bowman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisch, Michael, Michael Grabner, Daniel S. Mytelka, et al.. (2020). <p>Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer</p>. Cancer Management and Research. Volume 12. 1535–1541. 1 indexed citations
2.
Zhu, Andrew X., Ryan David Nipp, Richard S. Finn, et al.. (2020). Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials. ESMO Open. 5(4). e000797–e000797. 21 indexed citations
3.
Pérol, M., Katherine B. Winfree, Gebra Cuyún Carter, et al.. (2019). Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer. Lung Cancer. 131. 6–13. 8 indexed citations
4.
5.
Bowman, Lee, et al.. (2017). Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease. Journal of Vascular Surgery. 67(1). 356–356. 36 indexed citations
6.
Matza, Louis S., Kristina S. Boye, David Feeny, et al.. (2015). The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation. The European Journal of Health Economics. 17(8). 979–990. 20 indexed citations
7.
Karve, Sudeep, Gregory L. Price, Keith L. Davis, et al.. (2014). Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers. BMC Health Services Research. 14(1). 555–555. 28 indexed citations
8.
Byfield, Stacey DaCosta, Emily Nash Smyth, Daniel S. Mytelka, Lee Bowman, & April Teitelbaum. (2013). Healthcare costs, treatment patterns, and resource utilization among pancreatic cancer patients in a managed care population. Journal of Medical Economics. 16(12). 1379–1386. 19 indexed citations
9.
Matza, Louis S., et al.. (2012). PMS60 The Time Horizon Matters: Exploratory Results Varying the Time Horizon in Time Trade-Off and Standard Gamble Utility Elicitation. Value in Health. 15(7). A450–A450. 1 indexed citations
10.
Mauskopf, Josephine, et al.. (2011). PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEM. Value in Health. 14(3). A22–A23. 1 indexed citations
11.
Kleinman, Leah, Jeffrey A. Lieberman, Sanjay Dubé, et al.. (2008). Development and psychometric performance of the schizophrenia objective functioning instrument: An interviewer administered measure of function. Schizophrenia Research. 107(2-3). 275–285. 33 indexed citations
12.
Kutikova, Lucie, Lee Bowman, Stella Chang, et al.. (2006). Medical costs associated with non-Hodgkin's lymphoma in the United States during the first two years of treatment. Leukemia & lymphoma. 47(8). 1535–1544. 38 indexed citations
13.
Chang, Stella, Stacey R. Long, Lucie Kutikova, et al.. (2006). Burden of Pancreatic Cancer and Disease Progression: Economic Analysis in the US. Oncology. 70(1). 71–80. 23 indexed citations
14.
Kutikova, Lucie, Lee Bowman, Stella Chang, et al.. (2005). The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer. 50(2). 143–154. 99 indexed citations
15.
Bowman, Lee, et al.. (2000). Shorter hospital stays for angioplasty patients who receive abciximab.. PubMed. 12(4). 179–86. 7 indexed citations
16.
Bowman, Lee, et al.. (1998). Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications.. PubMed. 19 Suppl D. D59–66. 13 indexed citations
17.
18.
Bowman, Lee, et al.. (1996). Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiology and Drug Safety. 5(1). 9–18. 46 indexed citations
19.
Bowman, Lee, et al.. (1994). Computerized drug-use evaluation. American Journal of Health-System Pharmacy. 51(3). 363–367. 4 indexed citations
20.
Bowman, Lee, et al.. (1989). Aminoglycoside Dosing in Pediatric Patients. Therapeutic Drug Monitoring. 11(1). 38–43. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne-Françoise Gaudin Breakdown of academic impact, for papers by Jacqueline Brown Breakdown of academic impact, for papers by Michael Eaddy Breakdown of academic impact, for papers by Anuja Roy Breakdown of academic impact, for papers by K. Jack Ishak Breakdown of academic impact, for papers by Anita Burrell Breakdown of academic impact, for papers by Karen Welch Breakdown of academic impact, for papers by Dong D. Zhang Breakdown of academic impact, for papers by Irina Proskorovsky Breakdown of academic impact, for papers by Jennifer Christian
Rankless by CCL
2026